Red Cross Says J&J's Anti-Bleeding Patches Infringe Patents

Law360, New York (April 19, 2013, 4:52 PM EDT) -- Johnson & Johnson and two of its subsidiaries were hit with a suit in Texas federal court Tuesday by the American Red Cross and a biotechnology company that licenses two of its patents, saying J&J's anti-bleeding sealant patches infringe them.

According to the suit, sealant patches made by Israel-based J&J unit Omrix Biopharmaceuticals Ltd. and distributed in the U.S. by Ethicon Inc., another J&J unit, infringe two patents — U.S. Patent Numbers 7,189,410 and 7,196,054, both titled “Supplemented and Unsupplemented Tissue Sealants, Methods of Their Production and...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.